Embrace TDD: Post-Market Study to Evaluate Intrathecal Morphine as an Alternative to Systemic Opioids for Chronic Pain

Clinical trial NCT03761277 · COMPLETED

Trial details

NCT number: NCT03761277
Sponsor: MedtronicNeuro
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Non-malignant Pain Chronic Pain Pain, Back Pain, Leg

Start date: 2019-01-16
Primary completion: 2021-12-06
Enrollment: 93

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.